Genolution Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
86
- Stock Symbol
-
225220
- Investments
-
3
- Share Price
-
$1.30
- (As of Friday Closing)
Genolution General Information
Description
Genolution Inc is a biotechnology company that develops and provides RNAi-related products and services. Its products include siRNA, shRNA, miRNA, functional study, transfection, extraction products and detection products.
Contact Information
Website
www.genolution.co.krCorporate Office
- 63, Magokjungang 8-ro 3-gil
- Gangseo-gu
- Seoul, 07793
- South Korea
Corporate Office
- 63, Magokjungang 8-ro 3-gil
- Gangseo-gu
- Seoul, 07793
- South Korea
Genolution Stock Performance
As of 13-Nov-2026, Genolution’s stock price is $1.30. Its current market cap is $23.5M with 18.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.30 | $1.30 | $0.62 - $1.53 | $23.5M | 18.1M | 36.3K | -$0.18 |
Genolution Financials Summary
As of 30-Jun-2026, Genolution has a trailing 12-month revenue of $6.91M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 11,467 | 19,538 | 19,894 | 35,685 |
| Revenue | 6,912 | 6,608 | 5,230 | 7,466 |
| EBITDA | (2,908) | (7,407) | (4,486) | (5,285) |
| Net Income | (3,211) | (8,181) | (5,002) | (4,216) |
| Total Assets | 61,313 | 65,129 | 72,271 | 88,026 |
| Total Debt | 15,571 | 16,690 | 16,477 | 18,739 |
Genolution Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Genolution Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Genolution Signals
Genolution Investments (3)
Genolution’s most recent deal was a Corporate Asset Purchase with YG-1 (6,542.1 Square Meter Land and 6,353.47 Square Meter Building in Incheon, South Korea) for . The deal was made on 02-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| YG-1 (6,542.1 Square Meter Land and 6,353.47 Square Meter Building in Incheon, South Korea) | 02-May-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Hulux | 26-Oct-2021 | Seed Round | Drug Discovery | ||
| Cookie Horn Laser (1,061 Square Meters of Land and Building Property in Seoul, South Korea) | 19-Jan-2018 | Corporate Asset Purchase | Buildings and Property |
Genolution ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Genolution FAQs
-
When was Genolution founded?
Genolution was founded in 2006.
-
Where is Genolution headquartered?
Genolution is headquartered in Seoul, South Korea.
-
What is the size of Genolution?
Genolution has 86 total employees.
-
What industry is Genolution in?
Genolution’s primary industry is Other Devices and Supplies.
-
Is Genolution a private or public company?
Genolution is a Public company.
-
What is Genolution’s stock symbol?
The ticker symbol for Genolution is 225220.
-
What is the current stock price of Genolution?
As of 13-Nov-2026 the stock price of Genolution is $1.30.
-
What is the current market cap of Genolution?
The current market capitalization of Genolution is $23.5M.
-
What is Genolution’s current revenue?
The trailing twelve month revenue for Genolution is $6.91M.
-
What is Genolution’s annual earnings per share (EPS)?
Genolution’s EPS for 12 months was -$0.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process